Correction: Verkade, J.M.M.; et al. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies 2018, 7, 12

Jorge M. M. Verkade; Marloes A. Wijdeven; Remon Van Geel; Brian M. G. Janssen; Sander S. Van Berkel; Floris L. Van Delft; Antibodies Editorial Office

doi:10.3390/antib7030034

You are currently viewing a new version of our website. To view the old version click .

Correction to Antibodies 2018, 7(1), 12.

Correction

30 August 2018

Correction: Verkade, J.M.M.; et al. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies 2018, 7, 12

and

Synaffix BV, Industrielaan 63, 5349 AE Oss, The Netherlands

MDPI, St. Alban-Anlage 66, 4052 Basel, Switzerland

Author to whom correspondence should be addressed.

Antibodies2018, 7(3), 34;https://doi.org/10.3390/antib7030034

Version Notes

Order Reprints

The conflict of interest section of the published paper [1] has been updated as follows:

“All authors are employees of Synaffix BV, whose product HydraSpace was introduced in this paper.”

The manuscript will be updated and the original will remain online on the article webpage.

Reference

Verkade, J.M.M.; Wijdeven, M.A.; van Geel, R.; Janssen, B.M.G.; van Berkel, S.S.; van Delft, F.L. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody–Drug Conjugates. Antibodies 2018, 7, 12. [Google Scholar] [CrossRef]

© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Addendum: Hoffmann, C.; et al. Autoantibodies in Neuropsychiatric Disorders. Antibodies 2016, 5, 9

Relative Contribution of Framework and CDR Regions in Antibody Variable Domains to Multimerisation of Fv- and scFv-Containing Bispecific Antibodies